Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Alanine Racemase Mutant. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel S173Q/Q360Y mutant enzyme boosts D-alanine yield by 20% and stability 3-fold, offering cost-effective pharma intermediate solutions.